Edition:
India

Cipla Ltd (CIPL.BO)

CIPL.BO on Bombay Stock Exchange

602.25INR
3:39pm IST
Change (% chg)

Rs-3.75 (-0.62%)
Prev Close
Rs606.00
Open
Rs608.80
Day's High
Rs609.95
Day's Low
Rs598.25
Volume
99,839
Avg. Vol
212,358
52-wk High
Rs663.00
52-wk Low
Rs508.10

Chart for

About

Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered... (more)

Overall

Beta: 0.47
Market Cap(Mil.): Rs471,067.19
Shares Outstanding(Mil.): 804.69
Dividend: 2.00
Yield (%): 0.34

Financials

  CIPL.BO Industry Sector
P/E (TTM): 43.76 30.95 32.75
EPS (TTM): 13.38 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

Sensex, Nifty fall, oil stocks top drag

Indian shares fell on Wednesday, dragged by energy stocks such as Hindustan Petroleum Corp Ltd and Oil and Natural Gas Corp Ltd (ONGC) on rising concern that the government may ask state-owned oil firms to share the burden of higher petrol and diesel prices.

23 May 2018

Indian shares fall as oil companies slip; Vedanta hits over 10-month low

May 23 Indian shares fell on Wednesday pulled down by oil companies, while mining and energy conglomerate Vedanta Ltd hit an over 10-month low as protests against its copper plant in south India turned violent.

23 May 2018

BUZZ-India's Cipla posts biggest intraday gain in over 3 months on Q4 profit

** Cipla Ltd rises as much as 7.8 pct to 564.90 rupees - posts biggest intraday pct gain since Feb 8

23 May 2018

Cipla posts fourth quarter profit, misses estimates

Cipla Ltd, India's second-biggest drugmaker by market capitalization, posted a fourth-quarter profit on Tuesday, but missed street estimates.

22 May 2018

UPDATE 1-India's Cipla posts Q4 profit, misses estimates

May 22 Cipla Ltd, India's second-biggest drugmaker by market capitalization, posted a fourth-quarter profit on Tuesday, but missed street estimates.

22 May 2018

India's Cipla posts Q4 profit

May 22 Cipla Ltd, India's second-biggest drugmaker by market capitalization, posted a fourth-quarter profit on Tuesday, but missed analysts' estimates.

22 May 2018

BRIEF-India's Cipla Ltd Posts March Qtr Consol Profit

* MARCH QUARTER CONSOL NET PROFIT 1.79 BILLION RUPEES VERSUS LOSS OF 617.9 MILLION RUPEES LAST YEAR

22 May 2018

BRIEF-Cipla Partners With Mannkind For Marketing, Distribution Of Afrezza In India

* PARTNERS WITH MANNKIND FOR EXCLUSIVE MARKETING, DISTRIBUTION OF AFREZZA IN INDIA

09 May 2018

BRIEF-Mannkind And Cipla Enter An Exclusive Marketing And Distribution Agreement For Afrezza® In India

* MANNKIND AND CIPLA ENTER AN EXCLUSIVE MARKETING AND DISTRIBUTION AGREEMENT FOR AFREZZA® IN INDIA

09 May 2018

BRIEF-India's Cipla Gets Final Nod For Generic Vazculep, Others

* GETS FINAL NOD FOR GENERIC VAZCULEP, GENERIC PHENYLEPHRINE HYDROCHLORIDE INJECTION USP, 10 MG/ML SINGLE-DOSE VIAL, GENERIC AROMASIN

02 May 2018

Earnings vs. Estimates